C. R. Bard, Incorporated

730 Central Ave , New Providence, NJ 07974

Public
Healthcare & Pharmaceuticals - Medical Devices
around $10 - 20M
around 100 - 250
(908) 277-8000
(908) 277-8412


C. R. Bard, Inc. (Bard) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. As of December 31, 2011, the Company sold a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The Company participates in the markets for vascular, urology, oncology and surgical specialty products. Bard also has a product group of other products. Through subsidiaries and a joint venture, Bard markets its products to customers in over 100 countries outside the United States. The Company?s principal international markets were in Europe and Japan as of December 31, 2011. On November 10, 2011, Bard acquired Medivance, Inc. On December 16, 2011, the ... (Source: SEC reports)


Competitor - 1/7
Which company is more competitive with C. R. Bard, Incorporated?


117 Contacts at this company
Ronald Burkett
Director, Corporate Safety ...
John Butera
District Manager; Bard Peripheral Vascular ...
Roland Shepherd
Senior Product Manager
Beverly Schaner
Product Safety and Performance Clinician ...
Sean Boyle
Vice President Sales
Joe Urban
CEO
Kevin Bovee
Director of Quality at Albany Molecular ...
Ryan Belford
Area Sales Director

Oct 25, 2017 17:30:36
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on [...]

Oct 11, 2017 17:12:14
MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 26 cents per share [...]

Aug 28, 2017 19:18:48
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) today announced the LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval [...]

Aug 28, 2017 17:30:29
MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE:BCR) today announced the LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval [...]

Aug 8, 2017 20:31:15
MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ -- C. R. Bard, Inc. (NYSE: BCR) (\"Bard\") and Becton, Dickinson and Company (NYSE:  [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.